In a 2014 blog post, Thomas Insel, former director of the National Institute of Mental Health (NIMH) wrote: “Recent data suggest that ketamine, given intravenously, might be the most important breakthrough in antidepressant treatment in decades.”
According to an article in Nature; major depressive disorder affects around 16 percent of...